Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
07/2010
07/01/2010WO2010075517A2 Nucleoside analogs
07/01/2010WO2010072146A1 Isonucleoside compound, its preparation method and modified oligonucleotide
07/01/2010US20100168052 Treatment of EBV and KHSV Infection and Associated Abnormal Cellular Proliferation
07/01/2010US20100167411 Novel slc17-type transporter protein in mammal and use thereof
07/01/2010US20100167289 Multi-color time resolved fluorophores based on macrocyclic lanthanide complexes
07/01/2010US20100166780 CpG Oligonucleotide Analogs Containing Hydrophobic T Analogs with Enhanced Immunostimulatory Activity
07/01/2010CA2748034A1 Nucleoside analogs
07/01/2010CA2748016A1 Synthesis of purine nucleosides
06/2010
06/30/2010EP2202238A1 Nucleotide Compounds including a rigid linker
06/30/2010EP2201020A2 Method of producing 2' -deoxy-5-azacytidine (decitabine)
06/29/2010US7745614 genetic probes modified at the 5' terminus by a functional group, which is linked to the nucleic acid through an activating leaving group and a tether, that provide for detectable or functional changes following their release from the modified nucleic acid; kits for detecting of nucleic acid sequences
06/29/2010US7745598 CpG single strand deoxynucleotides for use as adjuvant
06/29/2010US7745591 phosphinocarboxylate and phosphonocarboxylate oligonucleotides having enhanced nuclease resistance
06/29/2010US7745420 stability, high effectiveness and low toxicity; for treating pulmonary/respiratory diseases such as cystic fibrosis, asthma, chronic bronchitis, chronic obstructive lung disease, eosinophilic bronchitis
06/29/2010US7745417 1,2-dihydro-2-pyridinone substituted with biotin, bromine or iodine photoreactive group, fluorescent molecule; artificial base pairs; aptamers, antisense agents, ribozymes
06/29/2010US7745415 Modulate immune cytokine activities; treat hepatitis C virus infection; mask active structure as the agent passes through lymphoid tissue lining the stomach, minimizing activation of this tissue and allowing for improved oral tolerability
06/29/2010CA2379734C Treatment of cancers
06/24/2010WO2010069047A1 Biosynthesis of cmp-legionaminic acid from fructose-6-p, and respective pathway intermediates, using novel gdp-linked precursors
06/24/2010US20100160620 N-pyrazole a2a receptor agonists
06/24/2010US20100160250 Method for treating inflammatory conditions
06/24/2010US20100160248 Isotopically modified compounds and their use as food supplements
06/24/2010US20100155590 Labeled transition metal complexes
06/24/2010CA2747214A1 Biosynthesis of cmp-legionaminic acid from fructose-6-p, and respective pathway intermediates, using novel gdp-linked precursors
06/23/2010EP2198872A1 Use of corrinoids for the treatment of skin diseases.
06/23/2010EP2198871A1 Use of corrinoids for the treatment of skin diseases.
06/23/2010EP2198870A1 Activator for blood coagulation factor vii promoter and utilization of the same
06/23/2010EP2197892A2 Method of producing nucleosides
06/23/2010EP2197274A1 Azacytidine analogues and uses thereof
06/23/2010CN101747170A Conjugated type coenzyme Q analogue, preparation method and application thereof
06/23/2010CN101029068B Synthesis of 2',3'-didesoxy-3'-deoxythymidine
06/22/2010US7741473 useful in treating diseases or conditions associated with platelet aggregation and/or platelet activation; cis-[6-(6-Amino-purin-9-yl)-2-styryl-tetrahydro-furo[3,4-d][1,3]dioxol-4-yl]-methanol
06/22/2010US7741457 6-modified bicyclic nucleic acid analogs
06/22/2010US7741295 Detecting activity of a Silent information regulator 2 by combining the composition with adenosine 5'-diphosphate and an acetylated Sir2 peptide substrate to deacetylate the peptide, and identifying 2'/3'-O-acetyl-ADP-ribose in the mixture to determine the presence of Sir2 activity
06/17/2010WO2010066970A1 Novel flavour enhancer compounds
06/17/2010WO2010066699A1 Uracyl cyclopropyl nucleotides
06/17/2010WO2010066666A1 Process for the enzymatic production of cyclic diguanosine monophosphate employing a diguanylate cyclase comprising a mutated rxxd motif
06/17/2010US20100152434 Protein Kinase-binding Nucleosides and Associated Methods
06/17/2010US20100152433 Antiviral agent
06/17/2010US20100152424 Modular Nucleotide Compositions and Uses Therefor
06/17/2010US20100152128 Antiviral Agents
06/17/2010US20100152127 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
06/17/2010US20100152126 Beta-L-2'-Deoxy-Nucleosides for the Treatment of Hepatitis B
06/17/2010US20100151001 Ethynylated heterodinucleoside phosphate analogs, method for the production thereof, and use thereof
06/17/2010CA2747127A1 Process for the enzymatic production of cyclic diguanosine monophosphate employing a diguanylate cyclase comprising a mutated rxxd motif
06/17/2010CA2745523A1 Uracyl cyclopropyl nucleotides
06/16/2010EP2195447A1 Nucleotide triphosphate with an electroactive label conjugated to the gamma phosphate
06/16/2010EP2195326A1 Nucleoside derivatives as inhibitors of viral polymerases
06/16/2010CN1653079B Intercalator containing pseudonucleotide(s)
06/16/2010CN101735296A Method for preparing fludarabine
06/16/2010CN101735295A Preparation method of 2-amino-9-beta-D-arbinofuranose-6-methoxyl-9H-purine, midbody and preparation method thereof
06/16/2010CN101735294A Prodrug of L-nucleoside
06/16/2010CN101085797B Cryogel adsorption chromatography separation method for adenosine triphosphate
06/15/2010US7737263 insecticidal Cry35 proteins with enhanced properties as compared to wild-type Cry35 proteins. The modifications to these proteins were based in part on analysis of the atomic coordinates and three-dimensional (3D) structure of the 45 kDa 149B1 protein and other proteins in the Cry35 class
06/15/2010US7737127 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
06/15/2010US7737126 agonist of adenosine A2A receptor; treatment of asthma and chronic obstructive pulmonary disease; example: (2R,3R,4S,5R,2'R,3'R,4'S,5'R)-2,2'-{trans-1,4-cyclohexanediylbis[imino(2-{[2-(1-methyl-1H-imidazol-4-yl)ethyl]amino}-9H-purine-6,9-diyl)]}bis[5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol]
06/15/2010US7737089 Photoactivatable two-stage protective groups for the synthesis of biopolymers
06/15/2010CA2341700C Compositions and methods for treatment of mitochondrial diseases
06/10/2010WO2010065852A1 Dimeric avermectin and milbemycin derivatives
06/10/2010WO2010065787A2 Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
06/10/2010WO2010065671A2 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
06/10/2010WO2010065662A2 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1
06/10/2010WO2010065444A1 Drug composition cytotoxic for pancreatic cancer cells
06/10/2010WO2010063080A1 Amphiphile prodrugs
06/10/2010WO2010027512A3 Rna synthesis - phosphoramidites for synthetic rna in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic rna at the 3' - end
06/10/2010US20100145037 Dna amplification and sequencing using dna molecules generated by random fragmentation
06/10/2010US20100144664 Carbocyclic compounds and methods for treating emerging disease, including influenza and venezuela equine encephalitis virus
06/10/2010US20100144663 2, 6-Dinitrogen-Containing Substituted Purine Derivatives, The Preparation And Uses Thereof
06/10/2010US20100144655 Organic compounds
06/10/2010US20100143980 Synthesis of novel xylosides and potential uses thereof
06/10/2010CA2746003A1 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
06/10/2010CA2746001A1 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1
06/10/2010CA2745811A1 Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
06/10/2010CA2745434A1 Dimeric avermectin and milbemycin derivatives
06/10/2010CA2745265A1 Drug composition cytotoxic for pancreatic cancer cells
06/09/2010EP2193796A1 Use of corrinoids for the treatment of skin diseases
06/09/2010CN101730704A Stable salts of s-adenosylmethionine and process for the preparation thereof
06/09/2010CN101724075A Remodeling and glycoconjugation of peptides
06/09/2010CN101724002A Double salt formed by inosine and matrine or oxymatrine and application thereof in field of medicaments
06/09/2010CN101724001A Method for synthesizing medicinal pyrimidine derivative
06/09/2010CN101085798B Cryogel adsorption chromatography separation method for cytidine triphosphate
06/09/2010CN101031573B Heteroatoms-containing tricyclic compounds
06/08/2010US7732595 (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide; stable under relative humidity stress
06/08/2010US7732589 Primers for amplifying hsp 65 gene of mycobacterial species, hsp 65 gene fragments and method of identifying mycobacterial species with the same
06/08/2010US7732587 for treatment of TNF-mediated diseases, particularly including chronic inflammatory diseases
06/08/2010US7732484 Use of selective adenosine A1 receptor allosteric enhancers to manipulate angiogenesis
06/08/2010US7732424 Purine derivatives and methods of use thereof
06/08/2010US7732416 For protecting plants against parasitic feeding pests; also against the infestation of pets, especially cats and dogs, by fleas, ticks and nematodes; pesticides for crop protection
06/08/2010US7732128 Apparatus which utilizes atp concentration as a diagnostic indicator of cell viability; high throughput assay and cancer drug screening
06/08/2010CA2368135C Xylo-lna analogues
06/03/2010WO2010062404A2 N-fmoc nucleosides and phosphoramidites, and oligonucleotide synthesis
06/03/2010WO2010061402A2 An improved process for the preparation of capecitabine
06/03/2010US20100137577 Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient
06/03/2010US20100137576 5' o [(n acyl)amidophosphate] and 5' o [(n acyl)amidothiophosphate] and 5' o [(n acyl)amidodithiophosphate] and 5' o [(n acyl)amidoselenophosphate] derivatives of nucleosides and processes for the manufacture thereof
06/03/2010US20100137573 Synthesis of selenium-derivatized nucleosides, nucleotides, phosphoramidites, triphosphates and nucleic acids
06/03/2010US20100137240 Use of nucleoside derivatives as anti-koi herpes virus in fish
06/03/2010US20100137237 Process for the preparation of an (rp)-8-substituted camps
06/03/2010US20100136592 Photo-Induced Damage Mitigating Agents and Preparation and Methods of Use Thereof
06/02/2010EP2190439A2 Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity
06/02/2010EP1817317B1 Methods for preparing pimecrolimus
06/02/2010CN101717420A Novel method for synthesizing uridine
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 201